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Abstract

essential to consider patient experience and ability to navigate
this novel form of health care.

The aim of this study was to assess the patient experience with
teledermatology among new versus existing clinic patients in
the context of the rapid practice shift to teledermatology during
the COVID-19 pandemic. We analyzed survey responses from
184 teledermatology patients seen during COVID-19 at a major
Southeastern medical center from May 13th to June 5th 2020.
Overall patient-reported satisfaction with teledermatolo-gy
was high with the majority of respondents rating their overall
satisfaction as excellent (68%) or very good (18%). As
teledermatology experiences wider adoption with the COVID19 pandemic, it is essential to examine patient experience and
satisfaction with teledermatology.

Limited knowledge is available regarding patient satisfaction
and willingness to use teledermatology. Patient experience
likely differs based on patient-provider relationships and the
visit type, particularly if the patient is presenting for a new condition or for follow-up. Previous studies show high patient satisfaction when using teledermatology for skin referrals or new
consults.11–14 To our knowledge, there are no studies aimed at
examining patient satisfaction with teledermatology based on
visit type amid Covid-19. The goal of this study was to further
assess patient experiences with teledermatology, specifically
how experiences differ between new and follow-up patients.
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Methods

Introduction
The novel coronavirus disease-19 (COVID-19) pandemic has
created an urgent need to provide services while minimizing
exposure to patients and providers. With the rapid shift to emergent in-person encounters, many institutions had to remodel
their office-based dermatology practices into virtual clinics in a
matter of weeks.1,2 Consequently, the field of teledermatology
has received an explosion of attention and utilization. Teledermatology, or the remote delivery of dermatological services using telecommunication technologies, was first described as a
mechanism for providing services to rural populations.3 The
field has been slowly growing since it proved a valuable medium for such a visually focused specialty. 4 Previous studies
have found that teledermatology platforms provide shorter wait
times, improve ability to reach underserved populations, and
are more cost-effective.5–7
The exchange of information through video, audio, and imagery
has made it possible for dermatologists to visualize, diagnose,
and communicate with patients throughout the pandemic. This
rapid evolution has also allowed for recognition of virtual services by most health insurance organizations, and implementation of such encounters in electronic healthy records (EHR).
These changes have paved the way for teledermatology to remain a prominent communication method in the future of the
field. Of international dermatologists surveyed throughout the
pandemic, 71% stated that they planned to continue using teledermatology in the future.8 Other studies from the past decade
have shown similar satisfaction with teledermatology amongst
providers.9,10 However, prior to telehealth implementation , it is

We conducted a cross-sectional study of teledermatology patient satisfaction levels during COVID-19 at a major Southeastern medical center. The aim of this quality improvement project
was to measure patient satisfaction in the context of the
COVID-19 pandemic and rapid practice shift to teledermatology. We report this project in accordance with SQUIRE 2.0
guidelines (Standards for Quality Improvement Report Excellence). 15 This project was exempted from Institutional Review
Board approval.
Participants were dermatology outpatients treated at a large tertiary academic hospital. Patients attended telemedicine visits
for a variety of acute and chronic dermatologic conditions and
included both new and follow-up patients. At the conclusion of
telemedicine visits, patients were invited to complete a voluntary online quality improvement survey. The survey was
adapted from validated telehealth satisfaction surveys work and
refined by group consensus (CITE). The survey was recorded
using the online survey tool Qualtrics (Provo, UT). AmericanWell (video) and Doximity (video and telephone) HIPAAcompliant platforms were used to conduct telehealth visits. We
piloted the survey for two days among a group of 22 patients;
the survey underwent iterative changes based on patient and
provider feedback. The survey was administered from May 13 th
to June 5th 2020 to the patients of eight dermatologists participating in teledermatology visits. At the time of survey implementation, in-person visits were largely limited to urgent conditions. Of the 288 teledermatology patients seen during the
study period, 184 (64%) completed the survey.
The primary outcomes of this study were patient satisfaction
levels for new and follow-up patients. The secondary outcome
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was the reachability of teledermatology across the state of
North Carolina.
The primary exposures were patient type (new versus followup) and prior patient telehealth experience (yes/no). The data
were evaluated with an a priori plan using descriptive statistics.
Continuous measures were reported as means with standard deviations (SD). Categorical variables were reported as counts
and percentages. Age was converted from continuous scale to
categorical (<18, 19-34, 35-50, 51-64, and >65) for analysis,
based on prior telehealth studies. Fischer’s exact tests were
used for categorical variables given some analysis cell sizes of
less than 20. T-tests and one-way analysis of covariance
(ANOVA) were performed to determine differences in mean
between continuous variables. Geospatial maps were obtained
using Tableau Software (Seattle, WA). Stata SE 16.0 was used
to perform statistical analyses. A p-value <0.05 was considered
statistically significant.

and 2%=poor) and new (62%=excellent, 22%=very good,
12%=good, 3%=fair and 2%=poor) patients (Figure 2). Length
of wait time and length of time with provider were highly rated
among participants (Figure 3). Provider-related satisfaction ratings were similarly high among the entire cohort (Figure 4)

Results
Most teledermatology visits were for follow-up patients (67%)
and telehealth-naïve patients (58%). Table 1 outlines the demographic characteristics of the respondents. The mean age of respondents was 37.8 years, with 50 (27%) males and 134 (73%)
females. Most respondents were White (62%), with Black
(24%) and Hispanic/Latino (7%) the next most common. Fifty
percent of respondents had a bachelor’s or higher-level education degrees. The majority of respondents were privately insured (59%), while a large subset had public insurance (38%),
such as Medicare and Medicaid.

Figure 2. Patient rating of voice and visual quality of
telemedicine visit.

The majority of patients reported living in suburban areas
(47%), while rural (27%) and urban (26%) were less common.
Geospatial analysis based on zip code showed that the highest
density of patients hailed from counties in the central portion of
the state (Figure 1). These regions correspond to counties immediately surrounding the study’s tertiary hospital. Visit density decreased moving towards the outer, rural regions of the
state.
For all satisfaction measures, new patients reported higher satisfaction compared to follow-up patients (Figure 2). Participants rated satisfaction with the voice quality of visits lower,
with follow-up patient satisfaction lower (45%=excellent,
23%=very good, 25%=good, 4%=fair, 3%=poor) than new patient satisfaction (59%=excellent, 28%=very good, 11%=good,
2%=fair and 0% poor) (Figure 2).

Figure 3 – Patient rating of telemedicine visit duration

Figure 1. Geospatial analysis showing density of visits across
North Carolina by patient zip code.
Satisfaction with visual quality was slightly higher, in both follow-up (59%=excellent, 25%=very good, 16%=good, 5%=fair
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We found that overall patient satisfaction was high, with 68%
of patients rating their experience as excellent. These findings
of high overall patient satisfaction with telehealth are consistent
with prior teledermatology studies in the literature. (12-15) Additionally, we found that overall satisfaction with telehealth did
not vary significantly based on patient demographics, locations
of residence, patient education or insurance status.

Figure 4 - Patient satisfaction of Provider Interaction by new
versus follow-up patients
Overall patient-reported satisfaction with teledermatology was
high with the majority of respondents rating their overall satisfaction as excellent (68%) or very good (18%). Mean Likert
score for overall satisfaction with telehealth did not significantly differ by age, race/ethnicity, education level, residence,
or insurance status (p>0.05). New patients had a statistically
significant higher overall satisfaction with teledermatology
than follow-up patients (mean Likert 4.70 for new, 4.43 for follow-up; p=0.0275). There was no significant difference in
overall satisfaction by prior telehealth experience, video versus
telephone visit type, or platform type (Table 1).

Table 1. Overall Satisfaction by Patient and Visit
Characteristics.
Mean Likert Score
(SD)*

Characteristic
Patient type

p-value
0.0275

New

4.70 (0.08)

Follow-up
Prior telehealth experience

4.43 (0.08)

Yes

4.48 (0.10)

None

4.55 (0.07)

Video

4.54 (0.06)

0.5266

Visit type
Telephone

4.23 (0.257)

Doximity

4.47 (0.09)

AmericanWell

4.60 (0.08)

0.1722

Platform
0.2186

Other 4.00 (1.15)
*Mean Likert Score calculated as average of satisfaction
scores (1=Poor to 5=Excellent)

Discussion
With limited prior teledermatology studies evaluating patient
satisfaction, this study found high patient satisfaction across numerous key measures.

Our study specifically aimed to analyze the difference in patient
satisfaction based on patient type (new versus follow-up), with
the majority of patients surveyed were follow-up (67%), while
only 33% of surveyed patients were being seen by the dermatologist for the first time as a new consult. While our study did
not assess diagnosis or treatment types in our surveyed patients,
our primary goal was to analyze patient satisfaction by patient
type (new versus follow-up). Our results indicated that, compared to follow-up patients, new patients had a statistically significant higher overall satisfaction with teledermatology
(p=0.0275). Furthermore, new patients reported statistically
significant higher satisfaction on all satisfaction metrics in the
post-visit survey. We postulate that these findings may be due
to the fact that new patients did not have a prior experience with
the dermatologist they were seeing to be able to compare their
telehealth visit experience with an in-person experience.
Meanwhile, follow-up patients may have been more apt to compare their telehealth visit experience to those they had experienced in person with the provider. Follow-up patients may have
desired to continue those in-person visits in order to maintain
rapport and their relationship with the physician. Additionally,
because of comparing these prior in-person visits to teledermatology, patients may have considered an in-person visit to be
more thorough as compared to video. However, overall satisfaction of both new and follow-up patients was extremely positive, and the expansion of this service seemed to be well-received by patients.
Undoubtedly, the impacts of a national health crisis influenced
patients’ perception of care and likely influenced how willing
and engaged patients were in telehealth in a way that is unprecedented in prior studies. On March 17 2020, major roadblocks
to telemedicine were lifted including the Centers for Medicare
and Medicaid expanding access to telehealth by authorizing
video visit reimbursements and relaxing state licensure requirements for patients with Medicare. Further, the Office for Civil
Rights loosened HIPAA (Health Insurance Portability and Accountability Act) restrictions on telehealth vendors and covered
telehealth providers. For these reasons, amplifying the role of
telehealth has been regarded as a silver lining of the pandemic.
We suspect that at least a portion of the highly positive response
to teledermatology visits we found in our surveyed patients is
due to the ability for patients to avoid higher risk settings and
to continue social distancing at their homes. In addition, many
patients travel long distances to be seen by specialists at the
clinic and were pleased to save time, money, and energy by not
having to physically appear at the clinic. Although CMS assured payment parity for telehealth visits—and providers could
bill for telehealth visits at the same rate as in-person visits—
patients likely saved money overall by taking less time off of
work and not having to factor in gas for the trip to the clinic.
This study has several limitations. First, this study reports findings from a convenience sample of patients treated by eight participating dermatologists. Although patients were recruited
consecutively at the end of telehealth visits, some patients did
not stay on the phone or video call. Patients who were contacted
after their appointment were not as successfully reached and
thus less likely to consent to the study. Also, this study took
place at a single dermatology center at an academic institution.
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therefore, study findings may be generalized to the larger dermatology patient population.
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